Joshua T. Brumm - CEO & President, Director at Dyne Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & President, Director
Stock Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joshua T. Brumm since 4/23/2024

Holdings reported by Joshua T. Brumm for Dyne Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 538K $14M $25.93 Mar 11, 2024 Direct
Stock option (right to buy) 83.3K Mar 11, 2024 Direct Common Stock

Transactions reported by Joshua T. Brumm for Dyne Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.